Impact of cardiovascular comorbidities on COPD assessment test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: Protocol of the Chance study

BMJ Open

Volumn 5, Issue 7, 2015, Pages

  Smid, Dionne E ^a   Wilke, Sarah ^a   Jones, Paul W ^b   Muris, Jean W M ^c   Wouters, Emiel F M ^a,d   Franssen, Frits M E ^a,d   Spruit, Martijn A ^a  

^a Dept of Research and Education CIRO   (Netherlands)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; COPD ASSESSMENT TEST; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; PULMONARY REHABILITATION; QUESTIONNAIRE; REFERENCE VALUE; SECONDARY HEALTH CARE; TERTIARY HEALTH CARE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; FEMALE; KINESIOTHERAPY; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY CARE; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; EXERCISE THERAPY; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84941312993     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007536     Document Type: Article

References (45)

1. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
2. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic, Obstructive Pulmonary Disease. Updated 2015. [PDF file] http://www.goldcopd.com (updated January 2015.6-3-2015).
4. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999;116:1632-7.
5. Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 2010;104:849-57.
6. Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006;47:312-19.
7. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680-5.
8. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-9.
9. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:728-35.
10. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011;38:29-35.
11. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005;128:2640-6.
12. Rutten FH, Cramer MJ, Grobbee DE, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887-94.
13. Freixa X, Portillo K, Pare C, et al. Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J 2013;41:784-91.
14. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
15. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13.
16. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD 2012;9:12-15.
17. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
18. Spruit MA, Vanderhoven-Augustin I, Janssen PP, et al. Integration of pulmonary rehabilitation in COPD. Lancet 2008;371:12-13.
19. Metsemakers JF, Hoppener P, Knottnerus JA, et al. Computerized health information in The Netherlands: a registration network of family practices. Br J Gen Pract 1992;42:102-6.
20. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64.
21. Munnik P, Zanen P, Lammers JW. A comparison of lung function equipment with emphasis on interchangeability and methods. Physiol Meas 2006;27:445-55.
22. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.
23. van der Molen T, Miravitlles M, Kocks JW. COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis 2013;8:461-71.
24. Janssen DJ, Spruit MA, Uszko-Lencer NH, et al. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med 2011;14:735-43.
25. Wilke S, Smid DE, Spruit MA, et al. The 2014 Updated GOLD Strategy: a comparison of the various scenarios. J COPD F 2014;1:212-20.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
27. Mesquita R, Janssen DJ, Wouters EF, et al. Within-day test-retest reliability of the Timed Up & Go test in patients with advanced chronic organ failure. Arch Phys Med Rehabil 2013;94:2131-8.
28. Janssen DJ, Wouters EF, Schols JM, et al. Care dependency independently predicts two-year survival in outpatients with advanced chronic organ failure. J Am Med Dir Assoc 2013;14:194-8.
29. Schols AM, Wouters EF, Soeters PB, et al. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991;53:421-4.
30. Rutten EP, Spruit MA, Wouters EF. Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Respiratory medicine 2006;27:445-55.
31. Hernandes NA, Wouters EF, Meijer K, et al. Reproducibility of 6-minute walking test in patients with COPD. Eur Resp J 2011;38:261-7.
32. van't Hul A, Gosselink R, Kwakkel G. Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J Cardiopulm Rehabil 2003;23:143-50.
33. Pitta F, Troosters T, Probst VS, et al. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Resp J 2006;27:1040-55.
34. Nieuwenhuizen MG, de Groot S, Janssen TW, et al. Canadian Occupational Performance Measure performance scale: Validity and responsiveness in chronic pain. Journal of rehabilitation research and development 2014;51:727-46.
35. Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2014;2:195-203.
36. Herland K, Akselsen JP, Skjonsberg OH, et al. How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 2005;99:11-19.
37. Stoilkova A, Wouters EF, Spruit MA, et al. The relationship between coping styles and clinical outcomes in patients with COPD entering pulmonary rehabilitation. Copd 2013;10:316-23.
38. Franssen FM, Broekhuizen R, Janssen PP, et al. Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training. Medicine and science in sports and exercise 2005;37:2-9.
39. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-19.
40. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
41. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001;56:880-7.
42. De Soomer K, Claus L, Heyndrickx R, et al. Office spirometry: (un) reliability of some handheld spirometers. European Respiratory Society International Congress; Bercelona, Spain, 2013.
43. Houben CH, Spruit MA, Wouters EF, et al. A randomised controlled trial on the efficacy of advance care planning on the quality of end-of-life care and communication in patients with COPD: the research protocol. BMJ Open 2014;4:e004465.
44. Nakken N, Janssen DJA, van den Bogaart EHA, et al. An observational, longitudinal study on the home environment of people with chronic obstructive pulmonary disease: the research protocol of the Home Sweet Home study. BMJ Open 2014;4:e006098.
45. Auffray C, Charron D, Hood L. Predictive, preventive, personalized, participatory medicine: back to the future. Genome Med 2010;2:57.